Lu Gan
0000-0002-6816-3434
1 paper found
Refreshing results…
Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma
Missing publications? Search for publications with a matching author name.